Evonik consensus stays cautious, MDAX shares under analyst scrutiny
28.06.2026 - 14:11:18 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-28, 14:10.
Evonik Industries (DE000EVNK013) sits in the MDAX with a cautious analyst consensus on margins and earnings, while the shares trade on Xetra as part of the European chemicals sector alongside BASF and Covestro. According to recent analyst compilations, the stock attracts a mix of Buy, Hold and Sell ratings with a focus on portfolio streamlining and cost discipline.
What analysts report today
Evonik Industries is closely followed by both German and international research houses, including Deutsche Bank, UBS and Berenberg, which regularly update their views on the MDAX-listed chemicals group and its transformation strategy. Recent consensus data compiled by MarketScreener and finanzen.net show that a majority of analysts currently rate the Evonik stock as Hold, while a smaller group remains constructive with Buy recommendations based on expected efficiency gains and exposure to specialty chemicals demand.
The target price range reported by these houses spans a corridor around the current market price, reflecting cautious expectations for earnings growth and margin improvement over the next 12 to 24 months. Analysts frequently highlight Evonik’s progress in restructuring its portfolio, including prior divestments of non-core businesses, as a key driver for potential value creation and a leaner balance sheet. At the same time, they point to input cost volatility and global industrial demand as variables that can influence near-term profitability.
Chemicals sector comparison on Friday
In the European chemicals sector, Evonik competes with larger peers such as BASF and Covestro, which provide a useful benchmark for investors assessing valuation and earnings resilience in a mixed macro environment. Sector reports from international outlets like Reuters and Handelsblatt have recently described a muted demand backdrop in some industrial end markets, while specialty chemicals and consumer-related applications display more robust trends. Within this context, Evonik’s focus on specialty additives, nutrition products and performance materials positions the stock as a mid-sized player with diversified exposure across several value chains.
Weekly sector roundups show that chemicals stocks often trade in tandem when macro data such as purchasing managers’ indices or energy price developments move, although company-specific news, such as plant investments or divestments, can create deviations. For Evonik, investors monitor how the company balances capital allocation between maintenance, growth projects and shareholder returns, including dividends and potential buybacks, in comparison with BASF’s more integrated model and Covestro’s polymer focus. This comparative view helps frame the MDAX stock’s risk-reward profile within the broader STOXX Europe 600 chemicals cohort.
All news and analysis on the Evonik Industries shares
For more background, price data and prior corporate updates on Evonik Industries, the internal topic page and the company’s investor relations site provide additional detail.
How Evonik makes its money
Evonik Industries generates revenue primarily from specialty chemicals and advanced materials used in a wide range of applications, from high-performance plastics to nutrition and care products. A representative product segment is its additives and crosslinkers for coatings and adhesives, which help improve durability, weather resistance and processing characteristics in industrial and consumer applications. In addition, Evonik is active in animal nutrition, providing amino acids such as methionine, and in health and personal care ingredients, reflecting a diversified portfolio across cyclical and more defensive end markets.
Where the Evonik stock trades today
The Evonik Industries shares (DE000EVNK013) trade on Xetra, with the latest available quotation showing a price around the low- to mid-teens in euros as part of the MDAX index as of a recent trading session reported by Deutsche Börse. The stock participates in the broader STOXX Europe 600 benchmark for European equities, giving international investors standardized exposure to a German specialty chemicals group.
Key data on the Evonik Industries shares
- Company: Evonik Industries AG
- ISIN: DE000EVNK013
- WKN: EVNK01
- Ticker: EVK
- Trading venue: Xetra
- Price (as of 2026-06-26, 17:45): 18.50 EUR
- Market cap: 8.0 billion EUR (as of 2026-06-26)
- Sector / industry: Chemicals / Specialty chemicals
- Index membership: MDAX, STOXX Europe 600
- Next earnings date: 2026-08-09
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation to participate in any financial transaction. All data are based on sources believed to be reliable at the time of publication, but accuracy and completeness cannot be guaranteed.
